9
Views
33
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Purification of Core-Binding Factor, a Protein That Binds the Conserved Core Site in Murine Leukemia Virus Enhancers

&
Pages 89-102 | Received 12 Aug 1991, Accepted 07 Oct 1991, Published online: 01 Apr 2023

References

  • Alt, F. W., N. Rosenberg, V. Enea, E. Siden, and D. Baltimore. 1982. Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines. Mol. Cell. Biol. 2:386–400.
  • Baldwin, A. 1989. Methylation interference assay for analysis of DNA-protein interactions, p. 12.3.2–12.3.3. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates and Wiley-Interscience, New York.
  • Birkenmeyer, E. H., B. Gwynn, S. Howard, J. Garry, J. I. Gordon, W. H. Landschulz, and S. L. McKnight. 1989. Tissue specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 3:1146–1156.
  • Boral, A. L., S. A. Okenquist, and J. Lenz. 1989. Identification of the SL3-3 virus enhancer core as a T lymphoma cell-specific element. J. Virol. 63:76–84.
  • Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
  • Celander, D., and W. A. Haseltine. 1984. Tissue-specific transcription preference as a determinant of cell tropism and leuke- mogenic potential of murine retroviruses. Nature (London) 312:159–162.
  • Chakrabarti, L., M. Guyader, M. Alizon, M. D. Daniel, R. C. Desrosiers, P. Tiollais, and P. Sonigo. 1987. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (London) 328:543–547.
  • Chatis, P. A., C. A. Holland, J. W. Hartley, W. P. Rowe, and N. Hopkins. 1983. Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80:4408–4411.
  • Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Fredrickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancer of nondefective Friend virus confers erythroleukemogenicity on Moloney murine leukemia virus. J. Virol. 52:248–259.
  • Chodosh, L. 1989. Purification of DNA-binding proteins using biotin/streptavidin affinity systems, p. 12.6.5. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates and Wiley-Interscience, New York.
  • Curran, T., and B. R. Franza, Jr. 1988. Fos and jun: the AP-1 connection. Cell 55:395–397.
  • DesGroseillers, L., and P. Jolicoeur. 1984. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses. J. Virol. 52:448–456.
  • DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945–952.
  • DesGroseillers, L., E. Rassart, and P. Jolicoeur. 1983. Thymot- ropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. USA 80:4203–4207.
  • DesGroseillers, L., R. Villemur, and P. Jolicoeur. 1984. The high leukemogenic potential of Gross passage A murine leukemia virus maps in the region of the genome corresponding to the long terminal repeat and to the 3′ end of env. J. Virol. 47:24–32.
  • Fried, M., and D. M. Crothers. 1981. Equilibria and kinetics of Lac repressor operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:6505–6525.
  • Galas, D., and A. Schmitz. 1978. DNase footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res. 5:3157–3170.
  • Gamer, M. M., and A. Revzin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the E. coli lactose operon regulatory system. Nucleic Acids Res. 9:3047–3060.
  • Gillies, S. D., S. L. Morrison, V. T. Oi, and S. Tonegawa. 1983. A tissue specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717–728.
  • Golemis, E., Y. Li, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1989. Distinct segments in the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63:328–337.
  • Golemis, E., N. A. Speck, and N. Hopkins. 1990. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:534–542.
  • Grosschedl, R., D. Weaver, D. Baltimore, and F. Constantini. 1984. Introduction of a µ immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody. Cell 38:647–658.
  • Hager, D. A., and R. R. Burgess. 1980. Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal. Biochem. 109:76–86.
  • Halligan, B. D., and S. V. Desiderio. 1987. Identification of a DNA binding protein that recognizes the nonamer recombina- tional signal sequence of immunoglobulin genes. Proc. Natl. Acad. Sci. USA 84:7019–7023.
  • Hendrickson, W., and R. F. Schlief. 1985. A dimer of AraC protein contacts three adjacent major groove regions of the AraI DNA site. Proc. Natl. Acad. Sci. USA 82:3129–3133.
  • Henthorn, P., M. Kiledjian, and T. Kadesch. 1990. Two distinct transcription factors that bind the immunoglobulin enhancer µE5/κE2 motif. Science 247:467–470.
  • Herr, W., R. A. Sturm, R. G. Clerc, L. Corcoran, D. Baltimore, P. A. Sharp, H. H. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkin, and H. R. Horvitz. 1988. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513–1516.
  • Ishimoto, A., A. Adachi, K. Sakai, and M. Matsuyama. 1985. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia. Virology 141:30–42.
  • Johnson, P. F., W. H. Landschulz, B. J. Graves, and S. L. McKnight. 1987. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev. 1:133–146.
  • Kadesch, T., P. Zervos, and D. Ruezinsky. 1986. Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res. 14:8209–8221.
  • Kadonaga, J. T., and R. Tjian. 1986. Affinity purification of sequence-specific DNA binding proteins. Proc. Natl. Acad. Sci. USA 83:5889–5893.
  • Kemp, D. J., A. W. Harris, S. Cory, and J. M. Adams. 1980. Expression of the immunoglobulin Cµ gene in mouse T and B lymphoid and myeloid cell lines. Proc. Natl. Acad. Sci. USA 77:2876–2880.
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685.
  • Lenz, J. (Albert Einstein College of Medicine). Personal communication.
  • Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. E. Perkins, and W. A. Haseltine. 1984. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature (London) 308:467–470.
  • Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:696–700.
  • LoSardo, J. E., A. L. Boral, and J. Lenz. 1990. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity. J. Virol. 64:1756–1763.
  • LoSardo, J. E., L. A. Cupelli, M. K. Short, J. W. Berman, and J. Lenz. 1989. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells. J. Virol. 63:1087–1094.
  • Manley, N. R., M. A. O'Connell, P. A. Sharp, and N. Hopkins. 1989. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus. J. Virol. 63:4210–4223.
  • Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
  • Mercurio, F., and M. Karin. 1989. Transcription factors AP-3 and AP-2 interact with the SV40 enhancer in a mutually exclusive manner. EMBO J. 8:1455–1460.
  • Meusing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Benton, L. A. Lashy, and D. J. Capon. 1985. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 313:450–458.
  • Murre, C., M. Schonleber, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777–783.
  • Redondo, J. M., S. Hata, C. Brocklehurst, and M. S. Krangel. 1990. A T cell-specific transcriptional enhancer within the human T cell receptor δ locus. Science 247:1225–1229.
  • Renjifo, B., N. A. Speck, S. Winandy, N. Hopkins, and Y. Li. 1990. cis-acting elements in the U3 region of a simian immunodeficiency virus. J. Virol. 64:3130–3134.
  • Rosenfeld, P. J., and T. J. Kelly. 1986. Purification of nuclear factor 1 by DNA recognition site affinity chromatography. J. Biol. Chem. 261:1398–1408.
  • Santoro, C., N. Mermod, P. C. Andrews, and R. Tjian. 1988. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature (London) 334:218–224.
  • Singh, H., R. Sen, D. Baltimore, and P. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (London) 319:154–158.
  • Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101–1110.
  • Speck, N. A., B. Renjifo, E. Golemis, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233–242.
  • Speck, N. A., B. Renjifo, and N. Hopkins. 1990. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J. Virol. 64:543–550.
  • Spencer, D. M., Y.-H. Hsiang, J. P. Goldman, and D. H. Raulet. 1991. Identification of a T-cell-specific transcriptional enhancer located 3′ of Cγl in the murine T-cell receptor γ locus. Proc. Natl. Acad. Sci. USA 88:800–804.
  • Storb, U., C. Pinkert, B. Arp, P. Engler, K. Gollahon, J. Manoz, W. Brady, and R. L. Brinster. 1986. Transgenic mice with µ and κ genes encoding anti-phophorylcholine antibodies. J. Exp. Med. 164:627–641.
  • Thornell, A., and T. Grundstrom. 1991. Characterization of SEF1 transcriptional activators critical for T-lymphomagenicity of murine leukemia viruses, abstr. 259, p. 259. Abstr. RNA Tumor Viruses.
  • Thornell, A., B. Hallberg, and T. Grundstrom. 1988. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8:1625–1637.
  • Thornell, A., B. Hallberg, and T. Grundstrom. 1991. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65:42–50.
  • Vogt, M. 1982. Virus cloned from Rauscher virus complex induces erythroblastosis and thymic lymphoma. Virology 118:226–236.
  • Wang, S., N. Speck, and W. Lane (Harvard Microchemistry Facility). Unpublished data.
  • Weiher, H., M. Zonig, and P. Gruss. 1983. Multiple point mutations affecting the simian virus 40 enhancer. Science 219:626–631.
  • Weiss, R., N. Teich, H. Varmus, and J. Coffin (ed.). 1982. RNA tumor viruses, vol. 1. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Weiss, R., N. Teich, H. Varmus, and J. Coffin (ed.). 1985. RNA tumor viruses, vol. 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Winoto, A., and D. Baltimore. 1989. A novel, inducible and T cell-specific enhancer located at the 3′ end of the T cell receptor a locus. EMBO J. 8:729–733.
  • Wray, W., T. Bouklikas, V. P. Wray, and R. Hancock. 1981. Silver staining of proteins in polyacrylamide gels. Anal. Biochem. 118:197–203.
  • Xiao, J.-H., I. M. Davidson, J.-M. Garnier, and P. Chambon. 1991. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551–568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.